Transcription of IMI-PROTECT Benefit-Risk Group …
{{id}} {{{paragraph}}}
Example: bankruptcy
IMI-PROTECT Benefit-Risk Group …
Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium 1 IMI-PROTECT Benefit-Risk Group recommendations report recommendations for the methodology and visualisation techniques to be used in the assessment of benefit and risk of medicines Prepared on behalf of the protect Consortium by: Diana Hughes1 Ed A J Waddingham Shahrul Mt-Isa Alesia Goginsky Edmond Chan Gerald Downey Christine E. Hallgreen Kimberley S. Hockley Juhaeri Juhaeri Alfons Lieftucht Marilyn A. Metcalfe Rebecca A. Noel Larry Phillips Deborah Ashby2 and Alain Micaleff2 on behalf of IMI-PROTECT Work Package 5. 1 Team leader of IMI-PROTECT Work Package 5 Recommendation report 2 Co-leaders of IMI-PROTECT Work Package 5 Disclaimer: The processes described and conclusions drawn from the work presented herein relate solely to the testing of methodologies and representations for the evaluation of benefit and risk of medicines.
Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium 1 IMI-PROTECT Benefit-Risk Group RECOMMENDATIONS REPORT
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Effectiveness of school-based programs, Systematic and meta-analytic review, An Introduction to Survival Analysis, Analytic, CONCEPTUAL, Enterprise Data Analysis and Visualization, And Adolescent Personality and Behavior Third, CSOC Service Guidelines Clinical Criteria, CSOC – Service Guidelines Clinical Criteria